{"id":"https://openalex.org/W4411643446","doi":"https://doi.org/10.1016/j.esmoop.2025.105140","title":"10O Efficacy according to PD-L1 status in the BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) randomised phase III trial of first-line atezolizumab (atezo), chemotherapy (CT) and bevacizumab (bev) for metastatic, persistent or recurrent cervical cancer (R/M CC)","display_name":"10O Efficacy according to PD-L1 status in the BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) randomised phase III trial of first-line atezolizumab (atezo), chemotherapy (CT) and bevacizumab (bev) for metastatic, persistent or recurrent cervical cancer (R/M CC)","publication_year":2025,"publication_date":"2025-06-01","ids":{"openalex":"https://openalex.org/W4411643446","doi":"https://doi.org/10.1016/j.esmoop.2025.105140"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2025.105140","doi":"https://doi.org/10.1016/j.esmoop.2025.105140","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.105140","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925010099","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925010099","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071060598","display_name":"Ugo De Giorgi","orcid":"https://orcid.org/0000-0001-7520-2908","observed_orcids":["https://orcid.org/0000-0001-7520-2908"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"U. De Giorgi","raw_affiliation_strings":["MITO and Department of Medical Oncology, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRCCS, Meldola, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MITO and Department of Medical Oncology, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRCCS, Meldola, Italy","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048711690","display_name":"Luigi Mansi","orcid":"https://orcid.org/0000-0001-8258-5134","observed_orcids":["https://orcid.org/0000-0001-8258-5134"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Mansi","raw_affiliation_strings":["GINECO and Department of Medical Oncology, CHRU Besan\u00e7on - H\u00f4pital Jean Minjoz, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GINECO and Department of Medical Oncology, CHRU Besan\u00e7on - H\u00f4pital Jean Minjoz, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080108767","display_name":"J. Martinez-Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150677","display_name":"Hospital Universitario Virgen de la Arrixaca","ror":"https://ror.org/058thx797","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210150677"]},{"id":"https://openalex.org/I4210154151","display_name":"Spanish Ovarian Cancer Research Group","ror":"https://ror.org/04zw2sa68","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210154151"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Martinez-Garcia","raw_affiliation_strings":["GEICO and Medical Oncology Department, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, El Palmar, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GEICO and Medical Oncology Department, Hospital Cl\u00ednico Universitario Virgen de la Arrixaca, El Palmar, Spain","institution_ids":["https://openalex.org/I4210150677","https://openalex.org/I4210154151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028946644","display_name":"Guillermo Javierre Villacampa","orcid":"https://orcid.org/0000-0003-4868-6585","observed_orcids":["https://orcid.org/0000-0003-4868-6585"]},"institutions":[{"id":"https://openalex.org/I4210133410","display_name":"Solti","ror":"https://ror.org/03xb7kp74","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210133410"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"G. Villacampa","raw_affiliation_strings":["Statistics Unit, Vall d\u2019Hebron Institute of Oncology (VHIO) and SOLTI Breast Cancer Research Group, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics Unit, Vall d\u2019Hebron Institute of Oncology (VHIO) and SOLTI Breast Cancer Research Group, Barcelona, Spain","institution_ids":["https://openalex.org/I4210133410","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065827694","display_name":"Munetaka Takekuma","orcid":"https://orcid.org/0000-0002-0807-1845","observed_orcids":["https://orcid.org/0000-0002-0807-1845"]},"institutions":[{"id":"https://openalex.org/I4210088324","display_name":"Shizuoka Cancer Center","ror":"https://ror.org/0042ytd14","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210088324"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Takekuma","raw_affiliation_strings":["JGOG and Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"JGOG and Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan","institution_ids":["https://openalex.org/I4210088324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067980172","display_name":"Kristina Yvonne Lindemann","orcid":"https://orcid.org/0000-0002-2162-0175","observed_orcids":["https://orcid.org/0000-0002-2162-0175"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]},{"id":"https://openalex.org/I184942183","display_name":"University of Oslo","ror":"https://ror.org/01xtthb56","country_code":"NO","type":"education","lineage":["https://openalex.org/I184942183"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"K. Lindemann","raw_affiliation_strings":["NSGO-CTU and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, and Department of Surgical Oncology, Section for Gynecological Oncology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NSGO-CTU and Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, and Department of Surgical Oncology, Section for Gynecological Oncology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175","https://openalex.org/I184942183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069415804","display_name":"Linn Lena Woelber","orcid":"https://orcid.org/0000-0002-9578-3049","observed_orcids":["https://orcid.org/0000-0002-9578-3049"]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"L. Woelber","raw_affiliation_strings":["AGO and Gynecology Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AGO and Gynecology Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110273473","display_name":"Destin R. Black","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089730","display_name":"Willis-Knighton Cancer Center","ror":"https://ror.org/00am3vk94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210089730"]},{"id":"https://openalex.org/I81020160","display_name":"Louisiana State University Health Sciences Center Shreveport","ror":"https://ror.org/03151rh82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121820613","https://openalex.org/I81020160"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Black","raw_affiliation_strings":["Willis-Knighton Cancer Center, LSU Health Shreveport, Shreveport, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Willis-Knighton Cancer Center, LSU Health Shreveport, Shreveport, United States of America","institution_ids":["https://openalex.org/I4210089730","https://openalex.org/I81020160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029949952","display_name":"Dionyssios Katsaros","orcid":"https://orcid.org/0000-0002-8267-1494","observed_orcids":["https://orcid.org/0000-0002-8267-1494"]},"institutions":[{"id":"https://openalex.org/I4210106593","display_name":"Ospedale Sant'Anna","ror":"https://ror.org/010d4kb47","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903","https://openalex.org/I4210106593"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D. Katsaros","raw_affiliation_strings":["MaNGO and Department of Surgical Sciences, St Anna Hospital, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MaNGO and Department of Surgical Sciences, St Anna Hospital, Turin, Italy","institution_ids":["https://openalex.org/I4210106593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073787373","display_name":"Beno\u00eet You","orcid":"https://orcid.org/0000-0002-3177-8857","observed_orcids":["https://orcid.org/0000-0002-3177-8857"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. You","raw_affiliation_strings":["GINECO and Oncology Department, Hospices Civils de Lyon \u2013 CH Lyon Sud, Pierre-B\u00e9nite, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GINECO and Oncology Department, Hospices Civils de Lyon \u2013 CH Lyon Sud, Pierre-B\u00e9nite, France","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026247805","display_name":"Ana Godoy-Ort\u00edz","orcid":"https://orcid.org/0000-0002-5503-6946","observed_orcids":["https://orcid.org/0000-0002-5503-6946"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210157481","display_name":"Hospital Cl\u00ednico Universitario Virgen de la Victoria","ror":"https://ror.org/05xxs2z38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210157481"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4210164724","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga","ror":"https://ror.org/05n3asa33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210164724"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Godoy Ortiz","raw_affiliation_strings":["GEICO, Medical Oncology Unit, Virgen de la Victoria University Hospital, Malaga, Spain, IBIMA Plataforma BIONAND, M\u00e1laga, Spain, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Oncolog\u00eda CIBERONC-ISCIII, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GEICO, Medical Oncology Unit, Virgen de la Victoria University Hospital, Malaga, Spain, IBIMA Plataforma BIONAND, M\u00e1laga, Spain, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Oncolog\u00eda CIBERONC-ISCIII, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4210157481","https://openalex.org/I4210158561","https://openalex.org/I4210164724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043150656","display_name":"Akira Yabuno","orcid":"https://orcid.org/0000-0002-1221-0609","observed_orcids":["https://orcid.org/0000-0002-1221-0609"]},"institutions":[{"id":"https://openalex.org/I4210132452","display_name":"Saitama International Medical Center","ror":"https://ror.org/03ftky336","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132452"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"A. Yabuno","raw_affiliation_strings":["JGOG and Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"JGOG and Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Japan","institution_ids":["https://openalex.org/I4210132452","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019365560","display_name":"A-C. Hardy-Bessard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A-C. Hardy-Bessard","raw_affiliation_strings":["GINECO and Medical Oncology Department, Centre Armoricain d\u2019Oncologie, Pl\u00e9rin, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GINECO and Medical Oncology Department, Centre Armoricain d\u2019Oncologie, Pl\u00e9rin, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109848938","display_name":"Maria Jesus Rubio P\u00e9rez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123675","display_name":"Hospital Universitario Reina Sof\u00eda","ror":"https://ror.org/02vtd2q19","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210123675"]},{"id":"https://openalex.org/I4210154151","display_name":"Spanish Ovarian Cancer Research Group","ror":"https://ror.org/04zw2sa68","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210154151"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M.J. Rubio P\u00e9rez","raw_affiliation_strings":["GEICO and Medical Oncology Department, Reina Sofia University Hospital of C\u00f3rdoba, C\u00f3rdoba, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GEICO and Medical Oncology Department, Reina Sofia University Hospital of C\u00f3rdoba, C\u00f3rdoba, Spain","institution_ids":["https://openalex.org/I4210123675","https://openalex.org/I4210154151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074178269","display_name":"Sophie Abadie Lacourtoisie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106090","display_name":"Institut de Canc\u00e9rologie de l'Ouest","ror":"https://ror.org/01m6as704","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210106090"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S. Abadie Lacourtoisie","raw_affiliation_strings":["GINECO and Institut de Canc\u00e9rologie de l\u2019Ouest, Centre Paul Papin, Angers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GINECO and Institut de Canc\u00e9rologie de l\u2019Ouest, Centre Paul Papin, Angers, France","institution_ids":["https://openalex.org/I4210106090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080563906","display_name":"L. Fari\u00f1as Madrid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210154151","display_name":"Spanish Ovarian Cancer Research Group","ror":"https://ror.org/04zw2sa68","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210154151"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"L. Fari\u00f1as Madrid","raw_affiliation_strings":["GEICO and Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GEICO and Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210154151","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112213274","display_name":"William Mina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091932","display_name":"L\u2019Institut du Cancer Courlancy Reims","ror":"https://ror.org/00jfmd461","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210091932"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"W.G. Mina","raw_affiliation_strings":["GINECO and Medical Oncology Department, Institut du Cancer Courlancy Reims, Reims, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GINECO and Medical Oncology Department, Institut du Cancer Courlancy Reims, Reims, France","institution_ids":["https://openalex.org/I4210091932"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Lorusso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D. Lorusso","raw_affiliation_strings":["MITO and Gynecologic Oncology Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, and Ospedale Humanitas San Pio X, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MITO and Gynecologic Oncology Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, and Ospedale Humanitas San Pio X, Milan, Italy","institution_ids":["https://openalex.org/I2802557943","https://openalex.org/I4210153126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009392040","display_name":"Hanna Mellin Dahlstrand","orcid":"https://orcid.org/0000-0002-6166-3532","observed_orcids":["https://orcid.org/0000-0002-6166-3532"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"H. Dahlstrand","raw_affiliation_strings":["NSGO-CTU and Department of Gynecologic Oncology, Theme Cancer, Karolinska University Hospital and Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NSGO-CTU and Department of Gynecologic Oncology, Theme Cancer, Karolinska University Hospital and Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067053417","display_name":"Ana Oaknin","orcid":"https://orcid.org/0000-0002-3592-7194","observed_orcids":["https://orcid.org/0000-0002-3592-7194"]},"institutions":[{"id":"https://openalex.org/I4210154151","display_name":"Spanish Ovarian Cancer Research Group","ror":"https://ror.org/04zw2sa68","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210154151"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Oaknin","raw_affiliation_strings":["GEICO and Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GEICO and Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210154151","https://openalex.org/I4387155398"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":29,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3910,"currency":"USD","value_usd":3910},"apc_paid":{"value":3910,"currency":"USD","value_usd":3910},"fwci":4.3603,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.93169586,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"10","issue":null,"first_page":"105140","last_page":"105140"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9359999895095825,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9359999895095825,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.04910000041127205,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7950000166893005},{"id":"https://openalex.org/keywords/recurrent-or-metastatic-cervical-cancer","display_name":"recurrent or metastatic cervical cancer","score":0.8080000281333923},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9120000004768372},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7329999804496765},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7749999761581421},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8769498467445374},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7009285688400269},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6778306365013123},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5251840353012085},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44891977310180664},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4432012438774109},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1900501549243927},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.09013894200325012},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.08503687381744385}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2025.105140","doi":"https://doi.org/10.1016/j.esmoop.2025.105140","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.105140","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925010099","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2025.105140","doi":"https://doi.org/10.1016/j.esmoop.2025.105140","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2025.105140","pdf_url":"https://www.esmoopen.com/action/showPdf?pii=S2059702925010099","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411643446.pdf","grobid_xml":"https://content.openalex.org/works/W4411643446.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388422868","https://openalex.org/W4392631147","https://openalex.org/W4402559938","https://openalex.org/W4403251087","https://openalex.org/W2947393144","https://openalex.org/W4389229205","https://openalex.org/W2982244781","https://openalex.org/W4414303219","https://openalex.org/W3091040812","https://openalex.org/W2953769340"],"abstract_inverted_index":{"Adding":[0],"atezo":[1,36,47],"to":[2,52],"first-line":[3],"CT":[4,38],"+":[5,37,39],"bev":[6,40],"for":[7],"R/M":[8,49],"CC":[9,50],"significantly":[10],"improved":[11],"the":[12,25],"dual":[13],"primary":[14],"endpoints":[15],"of":[16,46],"progression-free":[17],"survival":[18,22],"(PFS)":[19],"and":[20],"overall":[21],"(OS)":[23],"in":[24,48],"open-label":[26],"randomised":[27],"phase":[28],"III":[29],"BEATcc":[30],"trial":[31],"(NCT03556839).":[32],"Median":[33],"OS":[34],"with":[35],"exceeded":[41],"2.5":[42],"years.":[43],"The":[44],"effect":[45],"according":[51],"PD-L1":[53],"status":[54],"is":[55],"unknown.":[56]},"counts_by_year":[{"year":2026,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-10-10T00:00:00"}